Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Ian R. Mulrenin, Julian E. Garcia, Muluneh M. Fashe, Matthew Shane Loop, Melissa A. Daubert, Rachel Peragallo Urrutia & Craig R. Lee. (2021) The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. Expert Opinion on Drug Metabolism & Toxicology 17:11, pages 1261-1279.
Read now
Read now
Mary Clare Masters, Karen M. Krueger, Janna L. Williams, Lindsay Morrison & Susan E. Cohn. (2019) Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Review of Clinical Pharmacology 12:12, pages 1129-1143.
Read now
Read now
Georgios Schoretsanitis, Edoardo Spina, Christoph Hiemke & Jose de Leon. (2018) A systematic review and combined analysis of therapeutic drug monitoring studies for long-acting paliperidone. Expert Review of Clinical Pharmacology 11:12, pages 1237-1253.
Read now
Read now
Ellen Lu, Bing Wei Wang, Colleen Guimond, Anne Synnes, A Dessa Sadovnick, Leanne Dahlgren, Anthony Traboulsee & Helen Tremlett. (2013) Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance. Expert Review of Neurotherapeutics 13:3, pages 251-261.
Read now
Read now
J. G. Hengstler, H. Foth, T. Gebel, P.-J. Kramer, W. Lilienblum, H. Schweinfurth, W. Völkel, K.-M. Wollin & U. Gundert-Remy. (2011) Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A. Critical Reviews in Toxicology 41:4, pages 263-291.
Read now
Read now
Antoine Malek & Donald R Mattison. (2010) Drug development for use during pregnancy: impact of the placenta. Expert Review of Obstetrics & Gynecology 5:4, pages 437-454.
Read now
Read now
Hyunyoung Jeong. (2010) Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 689-699.
Read now
Read now
Italo Poggesi, Margherita Strolin Benedetti, Rhys Whomsley, Sophie Le Lamer, Mathieu Molimard & Jean-Baptiste Watelet. (2009) Pharmacokinetics in special populations. Drug Metabolism Reviews 41:3, pages 422-454.
Read now
Read now
Articles from other publishers (80)
Ahizechukwu C. Eke, Rahel D. Gebreyohannes, Maria Fernanda Scantamburlo Fernandes & Venkateswaran C. Pillai. (2023) Physiologic Changes During Pregnancy and Impact on Small‐Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response. The Journal of Clinical Pharmacology 63:S1.
Crossref
Crossref
Khairulanwar Burhanuddin & Raj Badhan. (2022) Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study. Metabolites 12:12, pages 1281.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2022. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
303
318
.
Ahizechukwu C. Eke. (2022) An update on the physiologic changes during pregnancy and their impact on drug pharmacokinetics and pharmacogenomics. Journal of Basic and Clinical Physiology and Pharmacology 33:5, pages 581-598.
Crossref
Crossref
Louise Fliedel, Khair Alhareth, Nathalie Mignet, Thierry Fournier & Karine Andrieux. (2022) Placental Models for Evaluation of Nanocarriers as Drug Delivery Systems for Pregnancy Associated Disorders. Biomedicines 10:5, pages 936.
Crossref
Crossref
Yusra Habib Khan, Nida Bokharee, Maria Rasheed, Amna Saifullah, Aisha Khokhar, Safia Akhtar Khan, Amjad Khan & Tauqeer Hussain Mallhi. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
141
159
.
Gerasimos Bastas, Jonathan Dallas, Patricia Blair Miller, Nicole Kloosterman & Ion Yannopoulos. (2021) Polypharmacy, Dosing Trends, and Drug-Drug Interaction Patterns After High-Level Limb Amputation Surgery. American Journal of Physical Medicine & Rehabilitation 100:11, pages 1087-1092.
Crossref
Crossref
Sarah Badaoui, Ashley M. Hopkins, A David Rodrigues, John O. Miners, Michael J. Sorich & Andrew Rowland. (2021) Application of Model Informed Precision Dosing to Address the Impact of Pregnancy Stage and CYP2D6 Phenotype on Foetal Morphine Exposure. The AAPS Journal 23:1.
Crossref
Crossref
Neelima Anup, Nimeet Desai, Kuldeep Rajpoot & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
145
162
.
Jolien J.M. Freriksen, Stein Schalkwijk, Angela P. Colbers, Khaled Abduljalil, Frans G.M. Russel, David M. Burger & Rick Greupink. (2020)
Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating
Ex Vivo
Placental Perfusion Data and Physiologically‐Based Pharmacokinetic Modeling
. Clinical Pharmacology & Therapeutics 107:6, pages 1352-1361.
Crossref
Crossref
Raj K S Badhan & Hannah Macfarlane. (2020) Quetiapine dose optimisation during gestation: a pharmacokinetic modelling study. Journal of Pharmacy and Pharmacology 72:5, pages 670-681.
Crossref
Crossref
Susanta K. Behura, Pramod Dhakal, Andrew M. Kelleher, Ahmed Balboula, Amanda Patterson & Thomas E. Spencer. (2019) The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy. Pharmacological Research 149, pages 104468.
Crossref
Crossref
Maisa N. Feghali & Steve N. Caritis. 2019. Evidence‐based Obstetrics and Gynecology. Evidence‐based Obstetrics and Gynecology
233
243
.
Nicola A. Philbrook, Victoria E. Restivo, Christine L. Belanger & Louise M. Winn. (2018) Gestational triphenyl phosphate exposure in C57Bl/6 mice perturbs expression of insulin-like growth factor signaling genes in maternal and fetal liver. Birth Defects Research 110:6, pages 483-494.
Crossref
Crossref
Patrick L. IversenPatrick L. Iversen. 2018. Molecular Basis of Resilience. Molecular Basis of Resilience
195
222
.
Sam Salman, Francesca Baiwog, Madhu Page-Sharp, Kay Kose, Harin A. Karunajeewa, Ivo Mueller, Stephen J. Rogerson, Peter M. Siba, Kenneth F. Ilett & Timothy M.E. Davis. (2017) Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling. International Journal of Antimicrobial Agents 50:4, pages 542-551.
Crossref
Crossref
Vamshi Krishna Jogiraju, Suvarchala Avvari, Rakesh Gollen & David R. Taft. (2017) Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations. Biopharmaceutics & Drug Disposition 38:7, pages 426-438.
Crossref
Crossref
Niloufar Marsousi, Jules A. Desmeules, Serge Rudaz & Youssef Daali. (2017) Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine. Journal of Pharmaceutical Sciences 106:9, pages 2380-2391.
Crossref
Crossref
Sam Salman, Francisca Baiwog, Madhu Page-Sharp, Susan Griffin, Harin A. Karunajeewa, Ivo Mueller, Stephen J. Rogerson, Peter M. Siba, Kenneth F. Ilett & Timothy M. E. Davis. (2017) Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. Antimicrobial Agents and Chemotherapy 61:5.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2016. Introduction to Drug Disposition and Pharmacokinetics. Introduction to Drug Disposition and Pharmacokinetics
211
232
.
A. Ouanounou & D. A. Haas. (2016) Drug therapy during pregnancy: implications for dental practice. British Dental Journal 220:8, pages 413-417.
Crossref
Crossref
Ali S. Faqi & Karsten A. Holm. 2017. Developmental and Reproductive Toxicology. Developmental and Reproductive Toxicology
1
16
.
Angelika Wieck & Margareta Reis. 2016. Comprehensive Women's Mental Health. Comprehensive Women's Mental Health
122
136
.
. 2016. Comprehensive Women's Mental Health. Comprehensive Women's Mental Health
81
136
.
Maisa Feghali, Raman Venkataramanan & Steve Caritis. (2015) Pharmacokinetics of drugs in pregnancy. Seminars in Perinatology 39:7, pages 512-519.
Crossref
Crossref
Sara K. Quinney, Avinash S. Patil & David A. Flockhart. (2014) Is personalized medicine achievable in obstetrics?. Seminars in Perinatology 38:8, pages 534-540.
Crossref
Crossref
Payman Shahabi, Gérard Siest, Urs A. Meyer & Sophie Visvikis-Siest. (2014) Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders. Pharmacology & Therapeutics 144:2, pages 134-161.
Crossref
Crossref
Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, David Baud, Monia Guidi, Chin B. Eap, Chantal Csajka & Nicolas Widmer. (2014) Médicaments et grossesse : modifications pharmacocinétiques et place du suivi thérapeutique pharmacologique. Therapies 69:3, pages 223-234.
Crossref
Crossref
Jin Kyung Lee, Hye Jin Chung, Liam Fischer, James Fischer, Frank J. Gonzalez & Hyunyoung Jeong. (2014) Human Placental Lactogen Induces CYP2E1 Expression via PI 3-Kinase Pathway in Female Human Hepatocytes. Drug Metabolism and Disposition 42:4, pages 492-499.
Crossref
Crossref
Bindia Jharap, Nanne K H de Boer, Pieter Stokkers, Daniel W Hommes, Bas Oldenburg, Gerard Dijkstra, C Janneke van der Woude, Dirk J de Jong, Chris J J Mulder, Ruurd M van Elburg & Adriaan A van Bodegraven. (2014) Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. Gut 63:3, pages 451-457.
Crossref
Crossref
Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan & Jashvant D. Unadkat. (2014) Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19. British Journal of Clinical Pharmacology 77:3, pages 554-570.
Crossref
Crossref
Xiaoshuang Wang, Jie Li, Guicheng Dong & Jiang Yue. (2014) The endogenous substrates of brain CYP2D. European Journal of Pharmacology 724, pages 211-218.
Crossref
Crossref
Thorsten BraunJohn R. ChallisJohn. P. NewnhamDeborah M. Sloboda. (2013) Early-Life Glucocorticoid Exposure: The Hypothalamic-Pituitary-Adrenal Axis, Placental Function, and Long-term Disease Risk. Endocrine Reviews 34:6, pages 885-916.
Crossref
Crossref
Nora Lee, Mary F. Hebert, Bhagwat Prasad, Thomas R. Easterling, Edward J. Kelly, Jashvant D. Unadkat & Joanne Wang. (2013) Effect of Gestational Age on mRNA and Protein Expression of Polyspecific Organic Cation Transporters during Pregnancy. Drug Metabolism and Disposition 41:12, pages 2225-2232.
Crossref
Crossref
Anders Helldén & Parvaz Madadi. (2013) Pregnancy and pharmacogenomics in the context of drug metabolism and response. Pharmacogenomics 14:14, pages 1779-1791.
Crossref
Crossref
María L. Ruiz, Aldo D. Mottino, Viviana A. Catania & Mary Vore. 2011. Comprehensive Physiology. Comprehensive Physiology
1721
1740
.
Evan D. Kharasch. 2011. Anesthetic Pharmacology. Anesthetic Pharmacology
72
89
.
Edward J. Hayes & Warwick D. Ngan Kee. 2013. Maternal Critical Care. Maternal Critical Care
150
159
.
. 2013. Maternal Critical Care. Maternal Critical Care
107
178
.
Wendy Pollock & Kate Morse. 2013. Maternal Critical Care. Maternal Critical Care
43
63
.
. 2013. Maternal Critical Care. Maternal Critical Care
1
106
.
Alice Ban Ke, Srikanth C. Nallani, Ping Zhao, Amin Rostami-Hodjegan, Nina Isoherranen & Jashvant D. Unadkat. (2013) A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women. Drug Metabolism and Disposition 41:4, pages 801-813.
Crossref
Crossref
Diana L. Shuster, Theo K. Bammler, Richard P. Beyer, James W. MacDonald, Jesse M. Tsai, Frederico M. Farin, Mary F. Hebert, Kenneth E. Thummel & Qingcheng Mao. (2013) Gestational Age-Dependent Changes in Gene Expression of Metabolic Enzymes and Transporters in Pregnant Mice. Drug Metabolism and Disposition 41:2, pages 332-342.
Crossref
Crossref
Marie C. Fortin, Lauren M. Aleksunes & Jason R. Richardson. (2013) Alteration of the Expression of Pesticide-Metabolizing Enzymes in Pregnant Mice: Potential Role in the Increased Vulnerability of the Developing Brain. Drug Metabolism and Disposition 41:2, pages 326-331.
Crossref
Crossref
Su-Young Choi, Kwi Hye Koh & Hyunyoung Jeong. (2013) Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone. Drug Metabolism and Disposition 41:2, pages 263-269.
Crossref
Crossref
Jose de Leon, Edoardo Spina & Francisco J. Diaz. (2013) Clobazam Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 35:1, pages 30-47.
Crossref
Crossref
Lu Gaohua, Khaled Abduljalil, Masoud Jamei, Trevor N. Johnson & Amin Rostami‐Hodjegan. (2012)
A pregnancy physiologically based pharmacokinetic (p‐
PBPK
) model for disposition of drugs metabolized by
CYP1A2
,
CYP2D6
and
CYP3A4
. British Journal of Clinical Pharmacology 74:5, pages 873-885.
Crossref
Crossref
Alexander V. LyubimovRonald E. White. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Doreen M. Matsui. (2012) Therapeutic Drug Monitoring in Pregnancy. Therapeutic Drug Monitoring 34:5, pages 507-511.
Crossref
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
1
30
.
Khaled Abduljalil, Penny Furness, Trevor N. Johnson, Amin Rostami-Hodjegan & Hora Soltani. (2012) Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy. Clinical Pharmacokinetics 51:6, pages 365-396.
Crossref
Crossref
M. Iqbal, M.C. Audette, S. Petropoulos, W. Gibb & S.G. Matthews. (2012) Placental drug transporters and their role in fetal protection. Placenta 33:3, pages 137-142.
Crossref
Crossref
James H. Fischer, Gloria E. Sarto, Mitra Habibi, Sarah J. Kilpatrick, Ruth E. Tuomala, Janice M. Shier, Lori Wollett, Patricia A. Fischer, Kinnari S. Khorana & Keith A. Rodvold. (2012) Influence of Body Weight, Ethnicity, Oral Contraceptives, and Pregnancy on the Pharmacokinetics of Azithromycin in Women of Childbearing Age. Antimicrobial Agents and Chemotherapy 56:2, pages 715-724.
Crossref
Crossref
Amitava Dasgupta. 2012. Therapeutic Drug Monitoring. Therapeutic Drug Monitoring
1
29
.
Yasuhiro Uno & Go Kito. (2011) Effect of Estradiol on Gene Expression Profile in Cynomolgus Macaque Liver: Implications for Drug-Metabolizing Enzymes. Drug Metabolism and Disposition 39:11, pages 2003-2007.
Crossref
Crossref
Urspeter Masche. (2011) Pharmakokinetische Veränderungen in der Schwangerschaft. pharma-kritik 32:16/17.
Crossref
Crossref
Daisy Goodman. (2011) Buprenorphine for the Treatment of Perinatal Opioid Dependence: Pharmacology and Implications for Antepartum, Intrapartum, and Postpartum Care. Journal of Midwifery & Women's Health 56:3, pages 240-247.
Crossref
Crossref
Su-Young Choi, Liam Fischer, Kyunghee Yang, Hyejin Chung & Hyunyoung Jeong. (2011) Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats. Biochemical Pharmacology 81:6, pages 777-782.
Crossref
Crossref
Kwi Hye Koh, Hui Xie, Ai-Ming Yu & Hyunyoung Jeong. (2011) Altered Cytochrome P450 Expression in Mice during Pregnancy. Drug Metabolism and Disposition 39:2, pages 165-169.
Crossref
Crossref
Maria Marino, Roberta Masella, Pamela Bulzomi, Ilaria Campesi, Walter Malorni & Flavia Franconi. (2011) Nutrition and human health from a sex–gender perspective. Molecular Aspects of Medicine 32:1, pages 1-70.
Crossref
Crossref
Stephen H. Curry & Robin Whelpton. 2010. Drug Disposition and Pharmacokinetics. Drug Disposition and Pharmacokinetics
169
185
.
Timothy ME DavisIvo Mueller & Stephen J Rogerson. (2010) Prevention and treatment of malaria in pregnancy. Future Microbiology 5:10, pages 1599-1613.
Crossref
Crossref
. (2010) Scientific Opinion on Bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of Bisphenol A. EFSA Journal 8:9, pages 1829.
Crossref
Crossref
Micaela Della Torre, Judith U. Hibbard, Hyunyoung Jeong & James H. Fischer. (2010) Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics. American Journal of Obstetrics and Gynecology 203:3, pages 254.e1-254.e12.
Crossref
Crossref
A. Y. Finlay & C. H. Smith. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
34
.
Mark N. Milton. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
218
.
Harin A. Karunajeewa, Sam Salman, Ivo Mueller, Francisca Baiwog, Servina Gomorrai, Irwin Law, Madhu Page-Sharp, Stephen Rogerson, Peter Siba, Kenneth F. Ilett & Timothy M. E. Davis. (2010) Pharmacokinetics of Chloroquine and Monodesethylchloroquine in Pregnancy. Antimicrobial Agents and Chemotherapy 54:3, pages 1186-1192.
Crossref
Crossref
Sam Salman, Stephen J. Rogerson, Kay Kose, Susan Griffin, Servina Gomorai, Francesca Baiwog, Josephine Winmai, Josin Kandai, Harin A. Karunajeewa, Sean J. O'Halloran, Peter Siba, Kenneth F. Ilett, Ivo Mueller & Timothy M. E. Davis. (2010) Pharmacokinetic Properties of Azithromycin in Pregnancy. Antimicrobial Agents and Chemotherapy 54:1, pages 360-366.
Crossref
Crossref
Yi Zhang, Lin Zhou, Jashvant D. Unadkat & Qingcheng Mao. (2009) Effect of Pregnancy on Nitrofurantoin Disposition in Mice. Journal of Pharmaceutical Sciences 98:11, pages 4306-4315.
Crossref
Crossref
Harin A. Karunajeewa, Sam Salman, Ivo Mueller, Francisca Baiwog, Servina Gomorrai, Irwin Law, Madhu Page-Sharp, Stephen Rogerson, Peter Siba, Kenneth F. Ilett & Timothy M. E. Davis. (2009) Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women. Antimicrobial Agents and Chemotherapy 53:10, pages 4368-4376.
Crossref
Crossref
Kirsi Vähäkangas & Päivi Myllynen. (2009) Drug transporters in the human blood-placental barrier. British Journal of Pharmacology 158:3, pages 665-678.
Crossref
Crossref
Hans Mielke & Ursula Gundert-Remy. (2009) Bisphenol A levels in blood depend on age and exposure. Toxicology Letters 190:1, pages 32-40.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
Huiqing Chen, Kyunghee Yang, Suyoung Choi, James H. Fischer & Hyunyoung Jeong. (2009) Up-Regulation of UDP-Glucuronosyltransferase (UGT) 1A4 by 17β-Estradiol: A Potential Mechanism of Increased Lamotrigine Elimination in Pregnancy. Drug Metabolism and Disposition 37:9, pages 1841-1847.
Crossref
Crossref
Sarah J. White, Elizabeth M. Laurenzana, William Brooks Gentry, Howard P. Hendrickson, David Keith Williams, Keith W. Ward & Samuel Michael Owens. (2009) Vulnerability to (+)-Methamphetamine Effects and the Relationship to Drug Disposition in Pregnant Rats during Chronic Infusion. Toxicological Sciences 111:1, pages 27-36.
Crossref
Crossref
Jose de Leon, Brian Greenlee, Jack Barber, Mohamed Sabaawi & Nirbhay N. Singh. (2009) Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities. Research in Developmental Disabilities 30:4, pages 613-669.
Crossref
Crossref
Rosa F. Yeh, Naser L. Rezk, Angela D. M. Kashuba, Julie B. Dumond, Hiba L. Tappouni, Hsiao-Chuan Tien, Ya-Chi Chen, Manoli Vourvahis, Amanda L. Horton, Susan A. Fiscus & Kristine B. Patterson. (2009) Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women. Antimicrobial Agents and Chemotherapy 53:6, pages 2367-2374.
Crossref
Crossref
Mark N. Milton. 2009. Drug Metabolism Handbook. Drug Metabolism Handbook
783
1000
.
Patricia Roy & Jennifer L. Payne. 2009. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis and Pharmacotherapy. Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis and Pharmacotherapy
253
269
.
Qingcheng Mao. (2008) BCRP/ABCG2 in the Placenta: Expression, Function and Regulation. Pharmaceutical Research 25:6, pages 1244-1255.
Crossref
Crossref